The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...

The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

It was announced last year that work at the GlaxoSmithKline plant in Ulverston would cease, which came to pass at the end of June.

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

The global vitamin D therapy market was valued at approximately USD 4.59 billion in 2022 and is projected to grow at an impressive growth rate of around 11.6% over the forecast period from 2023 to ...

Co-founder and CEO Jareeporn Jarukornsakul built industrial parks developer WHA from the ground up. Now she's facing the ...

U.S. Senator Maggie Hassan (D-NH) is intensifying her scrutiny of GSK Plc (NYSE:GSK) over the company's decision to pull its ...

GSK PLC GSK shares advanced 1.62% to £14.13 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.28% to 8,785.33. GSK PLC ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...

In a bold move to combat childhood vulnerability to preventable diseases, Save the Children's Immunisation Accelerator has ...